Physician
Asuncion, Merlyn
Asuncion, Merlyn was paid $929.35 by Medicaid between Jan 2018 and Dec 2024, across 53 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 77% of everything it billed.
33Billing provider infoASUNCION, MERLYN
VAN NUYS, CA 91411
VAN NUYS, CA 91411
33aNPI1679656193assigned 10/21/2006
33bProvider typeGeriatric Medicine (Internal Medicine) Physician
28Total paid$929.35
24GClaims30,061
24DCodes billed53
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Geriatric Medicine (Internal Medicine) Physician providers in California
Rank by total paid#69 of 86
Median peer was paid$14K
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,847 | $733.05 | |
| 2019 | 1,037 | $196.30 | |
| 2020 | 2,186 | $0.00 | |
| 2021 | 3,122 | $0.00 | |
| 2022 | 6,713 | $0.00 | |
| 2023 | 5,446 | $0.00 | |
| 2024incomplete | 9,710 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 77% | 3,145 | 2,582 | $718.83 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 23% | 1,928 | 1,566 | $210.52 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 2,654 | 2,625 | $0.00 |
| 85027 | 0% | 240 | 231 | $0.00 | |
| 80053 | Comprehensive metabolic panel | 0% | 2,923 | 2,800 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 4,662 | 4,262 | $0.00 |
| 1111F | 0% | 241 | 210 | $0.00 | |
| 82043 | 0% | 460 | 460 | $0.00 | |
| 3075F | 0% | 248 | 238 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 91 | 90 | $0.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 270 | 266 | $0.00 |
| 3079F | 0% | 263 | 242 | $0.00 |
41 more codes
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 445 | $0.00 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 1,584 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 103 | $0.00 |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 367 | $0.00 |
| 86780 | 0% | 193 | $0.00 | |
| 99441 | 0% | 319 | $0.00 | |
| 99443 | 0% | 147 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 359 | $0.00 |
| 1220F | 0% | 408 | $0.00 | |
| 92227 | 0% | 13 | $0.00 | |
| 3074F | 0% | 710 | $0.00 | |
| 90656 | 0% | 55 | $0.00 | |
| 87522 | Neg quan hep c or qual rna | 0% | 62 | $0.00 |
| 4450F | 0% | 285 | $0.00 | |
| 3044F | 0% | 385 | $0.00 | |
| 81001 | 0% | 13 | $0.00 | |
| 90686 | 0% | 25 | $0.00 | |
| 3080F | 0% | 15 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 12 | $0.00 |
| 90674 | 0% | 17 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 17 | $0.00 |
| 86703 | 0% | 444 | $0.00 | |
| 82540 | 0% | 460 | $0.00 | |
| 80061 | Lipid panel | 0% | 2,415 | $0.00 |
| 99442 | 0% | 880 | $0.00 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 891 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 270 | $0.00 |
| 82274 | 0% | 332 | $0.00 | |
| 3077F | 0% | 271 | $0.00 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 0% | 332 | $0.00 |
| 80074 | 0% | 42 | $0.00 | |
| 3078F | 0% | 892 | $0.00 | |
| 90750 | 0% | 13 | $0.00 | |
| 99204 | Doctor's office visit, new patient (more involved) | 0% | 25 | $0.00 |
| 85610 | 0% | 28 | $0.00 | |
| 91300 | 0% | 13 | $0.00 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 0% | 27 | $0.00 |
| 84439 | 0% | 12 | $0.00 | |
| 86480 | 0% | 12 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 18 | $0.00 |
| 77062 | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.